Clozapine versus typical neuroleptic medication for schizophrenia
about
Clozapine: a review of clinical practice guidelines and prescribing trendsAddressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment optionsHaloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersCarbamazepine for schizophreniaBenzodiazepines for schizophreniaHaloperidol versus first generation antipsychotics for schizophreniaPhysical health care monitoring for people with serious mental illnessQuetiapine versus placebo for schizophreniaClozapine dose for schizophreniaSulpiride augmentation for schizophreniaPharmacologic treatment of schizophreniaFluphenazine (oral) versus atypical antipsychotics for schizophreniaPrevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-AnalysisRandomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternativesProfile of minocycline and its potential in the treatment of schizophreniaCurrent approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatmentsLong-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials.Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness.Definitions and drivers of relapse in patients with schizophrenia: a systematic literature reviewValproate for schizophrenia.Chlorpromazine dose for people with schizophrenia.Past and present progress in the pharmacologic treatment of schizophrenia.Pharmacotherapy for treatment-resistant schizophrenia.Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia.Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials.Burning pain secondary to clozapine use: a case report.Skating on thin ice: pragmatic prescribing for medication refractory schizophreniaWhen can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.Clozapine prescribing in the UK: views and experience of consultant psychiatrists.First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptorsClozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of lifeAntipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practiceAdjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trialsAdjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children.New Schizophrenia Treatments Address Unmet Clinical Needs.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.The intersection of pharmacology, imaging, and genetics in the development of personalized medicine.Antipsychotics in children and adolescents with schizophrenia: a systematic review and meta-analysis.Clozapine dose for schizophrenia.Role of cytokine changes in clozapine-induced fever: A cohort prospective study.
P2860
Q21260307-347A5373-EBBC-46C8-B49E-DEEFCEDC9CB9Q22241447-53AEAE34-0322-4D3B-8C3E-BFE820CCE06BQ24186601-70CBA1CB-618F-4D8D-AB27-BBBDC6042028Q24194779-99E536C8-669A-48BF-9DCE-82989C0E557DQ24197501-4D62D081-8CDB-451D-9A6F-CAAF0B083FE7Q24198264-CFE65897-E64D-4C48-A97F-54DE38737BEDQ24201094-17AFF40E-8D4E-405B-8E16-BD02B0B6E7D8Q24202305-CDB156D4-A714-428D-9BE2-B217FB242DC3Q24203938-52012171-F6A4-4C4B-923B-3F2197D31F68Q24240818-4FEDBC32-FF7E-4557-8F96-2DF640CEE47BQ24604457-6CD08DEC-D044-47C3-8FDA-F745D12724C6Q26471188-B69B3128-A900-4F7C-A5D2-8CDF41BF25E9Q26748476-B76607AD-867E-4FD8-9474-60DDE5C160BDQ26863435-707090C9-1F88-4EBD-A8E9-7BCA95770597Q26864400-82950D02-EBDF-4E84-8641-C27A841331A5Q27003099-E9BC32B3-52D0-466C-BE9A-B4024748B115Q30490054-38C5ADC4-07CC-44E7-A53C-94694DFDD61CQ30759036-2790DD56-BA53-4AD9-B3F7-4B38C58525C5Q33589087-9971D378-5536-461A-960C-0229C45F8FF3Q34545761-F4BDBC32-E0F4-44DF-BD28-1847E9E4162DQ34681498-0FE6507A-D3F0-459B-9391-50EAD7F2A525Q34726953-FDEE7BED-C1B0-4740-ACA3-C255B2B4FDE3Q34879109-97E57BA3-2C51-4F6A-B6F9-59D394946DF8Q35061441-C31A4AFD-C3EA-4712-97FC-51EB2C9D54B7Q35256929-BA735BD9-6A7A-48C2-AAB4-814D537A2D58Q35359733-02C1D955-CABB-47BA-BFC7-4E5693FD76FDQ35709035-2596E4C0-F9B4-4908-BBFB-B21846B44D46Q35868866-097B16DA-2C7B-49F1-8609-4719661C2344Q35906545-8CF29CE1-F55E-4868-9E72-A18C2266E8D9Q36446517-F54B671E-AA6D-43AD-929E-06A8476E3526Q37011466-E058A317-4570-4429-9447-2CA65734666CQ37029622-A92E3EEA-6B9F-4E36-897B-50B9875EF947Q37228346-17EF4AFC-D543-49BE-8D4F-3C9178989325Q37409661-5E04925A-ECB8-4FA7-8999-161C59D2EAB6Q37605312-6CF8255A-9F0E-48BF-82CC-C3DC2F6A0FAFQ37653402-6060041F-23CE-48EF-8A75-C051DEDA7FB7Q37687997-270BCAF9-1376-499F-A5A3-511C4238FCB2Q38153030-D9D49EC3-E63C-465C-850A-444788354ED5Q38726056-8D7F175D-E8A3-4D97-80E5-28E9EFC76D7CQ40072330-5643F4C7-15EF-419B-97D1-2391966EC5C5
P2860
Clozapine versus typical neuroleptic medication for schizophrenia
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clozapine versus typical neuroleptic medication for schizophrenia
@ast
Clozapine versus typical neuroleptic medication for schizophrenia
@en
Clozapine versus typical neuroleptic medication for schizophrenia
@en-gb
Clozapine versus typical neuroleptic medication for schizophrenia
@nl
type
label
Clozapine versus typical neuroleptic medication for schizophrenia
@ast
Clozapine versus typical neuroleptic medication for schizophrenia
@en
Clozapine versus typical neuroleptic medication for schizophrenia
@en-gb
Clozapine versus typical neuroleptic medication for schizophrenia
@nl
prefLabel
Clozapine versus typical neuroleptic medication for schizophrenia
@ast
Clozapine versus typical neuroleptic medication for schizophrenia
@en
Clozapine versus typical neuroleptic medication for schizophrenia
@en-gb
Clozapine versus typical neuroleptic medication for schizophrenia
@nl
P2093
P2860
P3181
P1476
Clozapine versus typical neuroleptic medication for schizophrenia
@en
P2093
John Rathbone
Nahla Al-Haj Haasan
P2860
P304
P3181
P356
10.1002/14651858.CD000059.PUB2
P407
P50
P577
2009-01-21T00:00:00Z